Literature DB >> 25609453

Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication.

Young Seok Song1, Younghoon Kim2, Nam Yun Cho1, Han Kwang Yang3, Woo Ho Kim2, Gyeong Hoon Kang4,5.   

Abstract

BACKGROUNDS: Reportedly, the pyrosequencing methylation assay can produce inconsistent results between paired snap-frozen and formalin-fixed paraffin-embedded archival tissue samples. In this study, we assayed the methylation levels at four individual CpG sites of L1 using pyrosequencing and found that the methylation levels at individual CpG sites were different but were closely correlated between paired snap-frozen and formalin-fixed paraffin-embedded tissue samples. We aimed to determine whether low methylation status of L1 is associated with gastric cancer patient prognosis.
METHODS: We analyzed 434 formalin-fixed paraffin-embedded tissue samples of advanced gastric cancer for their methylation status at four CpG sites of L1 [nucleotide positions 328, 321, 318, and 306 of X58075 (Genbank)] using pyrosequencing, and correlated the L1 methylation level with clinicopathological features.
RESULTS: Older age at onset, males, tumor location at antrum or lower body, intestinal type, and lymphatic or venous invasion were associated with a low average methylation level of L1 at the two CpG sites 1 and 4 combined. The average methylation level of L1 at CpG sites 1 and 4 combined was significantly lower in microsatellite-stable and EBV-negative gastric cancers than in EBV-positive or microsatellite-unstable gastric cancers. Low methylation status of L1 was independently correlated with shorter overall survival and disease-free survival time.
CONCLUSION: Our findings indicate that the discrepancy in the methylation level of L1 between fresh tissue and formalin-fixed paraffin-embedded tissue samples depends on the CpG sites considered, and that the methylation status of L1 at CpG sites 1 and 4 combined could be utilized as a prognostic parameter for advanced gastric cancers.

Entities:  

Keywords:  Gastric cancer; Hypomethylation; Long interspersed element-1; Prognosis

Mesh:

Year:  2015        PMID: 25609453     DOI: 10.1007/s10120-015-0463-6

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  25 in total

1.  Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells.

Authors:  Adam R Karpf; Sei-ichi Matsui
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

Review 2.  Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.

Authors:  Yoshifumi Baba; Asuka Murata; Masayuki Watanabe; Hideo Baba
Journal:  Surg Today       Date:  2013-10-23       Impact factor: 2.549

3.  DNA methylation and genetic instability in colorectal cancer cells.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis.

Authors:  Krisanee Chalitchagorn; Shanop Shuangshoti; Nusara Hourpai; Narisorn Kongruttanachok; Pisit Tangkijvanich; Duangporn Thong-ngam; Narin Voravud; Virote Sriuranpong; Apiwat Mutirangura
Journal:  Oncogene       Date:  2004-11-18       Impact factor: 9.867

5.  DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis.

Authors:  Gyeong Hoon Kang; Sun Lee; Nam-Yun Cho; Tasha Gandamihardja; Tiffany I Long; Daniel J Weisenberger; Mihaela Campan; Peter W Laird
Journal:  Lab Invest       Date:  2007-12-24       Impact factor: 5.662

6.  Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis.

Authors:  Keun Hur; Paloma Cejas; Jaime Feliu; Juan Moreno-Rubio; Emilio Burgos; C Richard Boland; Ajay Goel
Journal:  Gut       Date:  2013-05-23       Impact factor: 23.059

7.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

8.  Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2.

Authors:  Chatchawit Aporntewan; Chureerat Phokaew; Jittima Piriyapongsa; Chumpol Ngamphiw; Chupong Ittiwut; Sissades Tongsima; Apiwat Mutirangura
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

9.  BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.

Authors:  Quan Zhu; Gerald M Pao; Alexis M Huynh; Hoonkyo Suh; Nina Tonnu; Petra M Nederlof; Fred H Gage; Inder M Verma
Journal:  Nature       Date:  2011-09-07       Impact factor: 49.962

10.  Inferring tumour purity and stromal and immune cell admixture from expression data.

Authors:  Kosuke Yoshihara; Maria Shahmoradgoli; Emmanuel Martínez; Rahulsimham Vegesna; Hoon Kim; Wandaliz Torres-Garcia; Victor Treviño; Hui Shen; Peter W Laird; Douglas A Levine; Scott L Carter; Gad Getz; Katherine Stemke-Hale; Gordon B Mills; Roel G W Verhaak
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  12 in total

1.  Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.

Authors:  Younghoon Kim; Ye-Young Rhee; Xianyu Wen; Nam-Yun Cho; Jeong Mo Bae; Woo Ho Kim; Gyeong Hoon Kang
Journal:  Gastric Cancer       Date:  2019-11-05       Impact factor: 7.370

2.  Combinatory low methylation statuses of SAT-α and L1 are associated with shortened survival time in patients with advanced gastric cancer.

Authors:  Younghoon Kim; Xianyu Wen; Seorin Jeong; Nam-Yun Cho; Woo Ho Kim; Gyeong Hoon Kang
Journal:  Gastric Cancer       Date:  2018-06-20       Impact factor: 7.370

3.  LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis.

Authors:  Juozas Kupcinskas; Ruta Steponaitiene; Cosima Langner; Giedre Smailyte; Jurgita Skieceviciene; Limas Kupcinskas; Peter Malfertheiner; Alexander Link
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

4.  Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer.

Authors:  Meihui Li; Younghoon Kim; Tae-Shin Kim; Nam-Yun Cho; Jeong Mo Bae; Woo Ho Kim; Gyeong Hoon Kang
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

5.  Differential Expression of Long Noncoding RNA HOTAIR in Intestinal Metaplasia and Gastric Cancer.

Authors:  Vytenis Petkevicius; Cosima Thon; Ruta Steponaitiene; Jurgita Skieceviciene; Dainius Janciauskas; Doerthe Jechorek; Peter Malfertheiner; Juozas Kupcinskas; Alexander Link
Journal:  Clin Transl Gastroenterol       Date:  2022-05-01       Impact factor: 4.396

6.  Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients.

Authors:  Duo Chen; Xianyu Wen; Young Seok Song; Ye-Young Rhee; Tae Hun Lee; Nam Yun Cho; Sae-Won Han; Tae-You Kim; Gyeong Hoon Kang
Journal:  Clin Epigenetics       Date:  2016-04-05       Impact factor: 6.551

7.  Methylation Levels of LINE-1 As a Useful Marker for Venous Invasion in Both FFPE and Frozen Tumor Tissues of Gastric Cancer.

Authors:  Jimin Min; Boram Choi; Tae-Su Han; Hyuk-Joon Lee; Seong-Ho Kong; Yun-Suhk Suh; Tae-Han Kim; Hwi-Nyeong Choe; Woo Ho Kim; Keun Hur; Han-Kwang Yang
Journal:  Mol Cells       Date:  2017-05-22       Impact factor: 5.034

8.  Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process.

Authors:  Xianyu Wen; Seorin Jeong; Younghoon Kim; Jeong Mo Bae; Nam Yun Cho; Jung Ho Kim; Gyeong Hoon Kang
Journal:  Clin Epigenetics       Date:  2017-01-13       Impact factor: 6.551

9.  Systematic pan-cancer analysis of tumour purity.

Authors:  Dvir Aran; Marina Sirota; Atul J Butte
Journal:  Nat Commun       Date:  2015-12-04       Impact factor: 14.919

10.  Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma.

Authors:  Seorin Jeong; Kyoungbun Lee; Xianyu Wen; Younghoon Kim; Nam-Yun Cho; Ja-June Jang; Gyeong Hoon Kang
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.